Globally, we show that depression patients have increased systemic inflammation, reflected on increased plasma levels of TNF-α and CCL2, increased TNF-α mRNA levels in PBMCs, and dysregulated expression of key and inflammation-related miRNAs in PBMCs. This evidence concerns the gene TNF and depressive disorder.